{
    "address": "Gasverksgatan 1",
    "city": "Lund",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W8713N105",
    "description": "SpectraCure AB engages in the research, development, and provision of equipment for cancer treatments. The company is headquartered in Lund, Skane and currently employs 17 full-time employees. The company went IPO on 2015-07-01. The firm specializes in cancer treatment technology. The firm develops photodynamic therapeutics based on photosensitive materials activated by laser. The firm's method is called interstitial photodynamic therapy (PDT). Interstitial PDT can be used for solid tumors in internal organs, such as cancer in the prostate, pancreas, and the head and neck area, among others. In addition, the Company offers software platform IDOSE for interstitial PDT treatment of solid cancer tumors in internal organs. With SpectraCure\u2019s interstitial PDT method, the patient is given a photoactivated drug - photosensitizer in combination with laser light guided by a dose control system.",
    "employeeTotal": "17.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Health Care",
    "ggroup": "Health Care Equipment & Services",
    "gind": "Health Care Equipment & Supplies",
    "gsector": "Health Care",
    "gsubind": "Health Care Equipment",
    "ipo": "2015-07-01",
    "isin": "SE0007158118",
    "logo": "",
    "marketCapitalization": 1043.193,
    "naics": "Navigational, Measuring, Electromedical, and Control Instruments Manufacturing",
    "naicsNationalIndustry": "Electromedical and Electrotherapeutic Apparatus Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Computer and Electronic Product Manufacturing",
    "name": "SpectraCure AB (publ)",
    "phone": "46462863770.0",
    "sedol": "BYR8YW4",
    "shareOutstanding": 97.131608,
    "state": "SKANE",
    "ticker": "SPEC.ST",
    "weburl": "http://spectracure.com/"
}